tbuckley/cabot-search huggingface dataset:
Rosai Dorfman's Disease with MAP2K1 Mutation Refractory to Chemotherapy with Complete Response to MEK Inhibitor Therapy: A Case Report
Authors: Gabriel Caixeta Vieira, Leticia Duarte Carvalho, Carolina Barbosa Carvalho do Carmo, Hans-Jochem Kolb, Waldineia Menezes de Almeida, Alexandre Nonino
Journal: Blood (2022)
Baseline PET Metabolic Tumor Volume Predicts Outcome in Advanced Follicular Lymphoma Patients Who Received First-Line Immunochemotherapy but Not Those Treated with Lenalidomide-Rituximab in the Phase III Relevance Study
Authors: Anne Ségolène Cottereau, Louis Rebaud, Judith Trotman, Pierre Feugier, Loretta J. Nastoupil, Emmanuel Bachy, Ian W. Flinn, Corinne Haioun, Loic Ysebaert, Nancy L. Bartlett, Hervé Tilly, René-Olivier Casasnovas, Romain Ricci, Cedric Portugues, Irène Buvat, Michel Meignan, Franck Morschhauser
Journal: Blood (2022)
Severe Persistent Cytopenias Following CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
Authors: Magdalena Corona De Lapuerta, Roni Shouval, Ana Alarcon Tomas, Jessica R. Flynn, Sean M. Devlin, Connie Lee Batlevi, Joshua A Fein, Sergio A Giralt, Richard J. Lin, Karthik Nath, Maria Lia Palomba, Allison Parascondola, Gunjan L. Shah, Gilles Salles, Michael Scordo, Moneeza Walji, Miguel-Angel Perales, Parastoo B Dahi
Journal: Blood (2022)
Adults with Severe or Moderately Severe Hemophilia B Receiving Etranacogene Dezaparvovec in the HOPE-B Phase 3 Clinical Trial Continue to Experience a Stable Increase in Mean Factor IX Activity Levels and Durable Hemostatic Protection after 24 Months’ Follow-up
Authors: Steven W. Pipe, Frank W.G. Leebeek, Michael Recht, Nigel S. Key, Susan Lattimore, Giancarlo Castaman, Michiel Coppens, David Cooper, Robert Gut, Sergio Slawka, Stephanie Verweij, Ricardo Dolmetsch, Yanyan Li, Paul E. Monahan, Wolfgang A. Miesbach
Journal: Blood (2022)
Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody®-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)
Authors: Andrew Spencer, Katrine Fladeland Iversen, Binod Dhakal, Maria Creignou, Jenny Chen, Ida H Hiemstra, Sieto Bosgra, Avani Badani, Esther C.W. Breij, Lauren K. Brady, A. Kate Sasser, Anders Malmberg, Henrik Gregersen, Markus Hansson, Annemiek Broijl, Maria-Victoria Mateos, Torben Plesner
Journal: Blood (2022)
Disease Characteristics and Treatment Outcomes with HLX01: A Real-World Study in Patients with B-Cell Non-Hodgkin Lymphoma in China
Authors: Jun Ma, Li Zhiming, Wei Xu, Yao Liu, Weili Zhao, Zhihua Yao, Kaiyang Ding, Yudan Wu, Hong Liu, Wenyu Li, Yirong Jiang, Li'e Lin, Zhigang Peng, Zhimin Zhai
Journal: Blood (2022)
Multi-Omics Profiling of JMML HSPCs Reveals Onco-Fetal Reprogramming and Identifies Novel Prognostic Biomarkers and Therapeutic Targets in High-Risk JMML
Authors: Mark Hartmann, Ling Hai, Joschka Hey, Maximilian Schönung, Valentin Maurer, Jovana Rajak, Sina Staeble, Jens Langstein, Katharina Bauer, Mariam Hakobyan, Laura Jardine, Sheila Bohler, Dominik Vonficht, Abdul-Habib Maag, Dirk Lebrecht, Kathrin M. Bernt, Roland Roelz, Tobias Boch, Eleonora Khabirova, Pavlo Lutsik, Oliver Stegle, Simon Haas, Muzlifah Haniffa, Sam Behjati, Jan-Philipp Mallm, Christian Buske, Stefan Fröhling, Christoph Plass, Charlotte M. Niemeyer, Christian Flotho, Marc Jan Bonder, Miriam Erlacher, Matthias Schlesner, Daniel B. Lipka
Journal: Blood (2022)
Durable Responses from Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase Ib/II Single Arm Study
Authors: Andrew J Davies, Josh Caddy, Katy McLaughlin, Christopher Wignall, Robert Waugh, Graham P. Collins, Louise Stanton, Geoff N Saunders, Thomas Cummin, Anna Schuh, Kirit M. Ardeshna, Andrew K. McMillan, John Radford, David John Lewis, Adam R Coleman, Gareth Griffiths, Cathy Burton, Sharon Barrans, Peter Johnson
Journal: Blood (2022)
Determinants of Resistance to Engineered T-Cell Therapies Targeting CD19 in Large B-Cell Lymphomas
Authors: Brian Sworder, David M. Kurtz, Stefan K. Alig, Matthew J Frank, Navika D. Shukla, Andrea Garofalo, Charles Macaulay, Mohammad Shahrokh Esfahani, Mari Olsen, James Hamilton, Hitomi Hosoya, Mark P Hamilton, Jay Y. Spiegel, John H. Baird, Mia Carleton, Alexander F.M. Craig, Sheren F. Younes, Bita Sahaf, Natasha Sheybani, Joseph Schroers-Martin, Chih Long Liu, Jean S Oak, Michael C. Jin, Sara Beygi, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Jason Westin, Michael S. Khodadoust, Yasodha Natkunam, Robbie G. Majzner, Crystal L. Mackall, Maximilian Diehn, David B. Miklos, Ash A. Alizadeh
Journal: Blood (2022)
Targeted Base Editing Strategies for Beta-Hemoglobinopathies
Authors: Giulia Hardouin, Panagiotis Antoniou, Pierre Martinucci, Tristan Felix, Marta Zoccheddu, Anne Chalumeau, Giacomo Frati, Sandra Manceau, Laure Joseph, Oriana Romano, Marina Cavazzana, Annarita Miccio
Journal: Blood (2022)
Integrative Analysis of Proteomics and Transcriptomics Reveals the Etrb As Novel Single Target and New Combinatorial Targets for Multiple Myeloma
Authors: Murat Cem Köse, Margaux Lejeune, Marie Jia Gou, Elodie Duray, Gael Cobraiville, Jacques Foguenne, Andre Gothot, Yves Beguin, Mariane Fillet, Jo Caers
Journal: Blood (2022)
Dual Targeting of HDM2 and PPM1D As a Novel Therapeutic Approach for Myelofibrosis
Authors: Bridget K Marcellino, Cara Clementelli, Kristin Beaumont, Christoph Schaniel, Min Lu, Karie Chen, Adena Russel, Ayman Mohammad, Daniel I Nathan, Jake Aronin, Alan H. Shih, Robert Sebra, Ronald Hoffman
Journal: Blood (2022)
Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study
Authors: Jean-Hugues Dalle, Peter Bader, Akif Yesilipek, Franco Locatelli, Julia Palma, Jacek Wachowiak, Herbert Pichler, Marianne Ifversen, Gergely Kriván, Jochen Buechner, Cristina Díaz-de-Heredia, Marc Bierings, Raquel Staciuk, Tayfun Gungor, Jacek Toporski, Adriana Balduzzi, Ulrike Poetschger, Christina Peters, Petr Sedlacek
Journal: Blood (2022)
Parallel Detection of Single-Cells and Extracellular Vesicles from Bone Marrow and Peripheral Blood Reveals Asymmetric Immunometabolic Profile in Acute Myeloid Leukemia
Authors: Dorian Forte, Rafael J. Argüello, Martina Barone, Samantha Bruno, Gianluca Cristiano, Michele Cavo, Antonio Curti
Journal: Blood (2022)
Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Overall Survival Results from the Phase 3 Apollo Study
Authors: Meletios A. Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksac, Eirini Katodritou, Philippe Moreau, Luca Baldini, Argiris Symeonidis, Jelena Bila, Albert Oriol, Maria-Victoria Mateos, Hermann Einsele, Ioannis Orfanidis, Tobias Kampfenkel, Weiping Liu, Michele Kosh, NamPhuong Tran, Robin Carson, Pieter Sonneveld
Journal: Blood (2022)
Heme and Iron Aggravate Tissue Damage in Sickle Cell Disease By Driving Macrophage Functional Reprogramming through the Coordinated Suppression of Efferocytosis and Mitochondrial Metabolism
Authors: Richa Sharma, S. Zebulon Vance, Ada Antypiuk, Deepa Manwani, Quentinn Pearce, James E. Cox, Xiuli An, Karina Yazdanbakhsh, Francesca Vinchi
Journal: Blood (2022)
The Role of Stathmin-1 in the Regulation of Hematopoietic Stem Cells
Authors: Luana Chiquetto Paracatu, Qian Dong, Zev J. Greenberg, Liana Valin, Nate Roundy, Christine R Zhang, Grant A Challen, Cliff Luke, Stephen M. Sykes, Laura G. Schuettpelz
Journal: Blood (2022)
CD82 Is Sufficient to Uniquely Identify Pluripotent Stem Cell-Derived Hemogenic Endothelium with the Hematopoietic Lineage Potency to Give Rise to Bona Fide Lymphocytes
Authors: Amanda D Yzaguirre, Carissa Dege, Daniel Sivalingam, Rahel Schnellmann, Alec Witty, Bahram Valamehr
Journal: Blood (2022)
Pretreatment with Tocilizumab Prior to the CD3 Bispecific Cevostamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Showed a Marked Reduction in Cytokine Release Syndrome Incidence and Severity
Authors: Suzanne Trudel, Nizar J. Bahlis, Andrew Spencer, Rayan Kaedbey, Paula Rodriguez Otero, Simon J Harrison, Chihunt Wong, Grant R. Goodman, Rin Nakamura, Voleak Choeurng, James Cooper, Maria-Victoria Mateos
Journal: Blood (2022)
A Novel Human OX40L-CAR-Treg Specifically Targets Activated Antigen-Presenting Cells and Effectively Controls T Cell Alloreactivity and Xeno-GvHD
Authors: Xianliang Rui, Francesca Alvarez Calderon, Ulrike Gerdemann, Connor McGuckin, Lorenzo Cagnin, Bruce R. Blazar, Victor Tkachev, Leslie S. Kean
Journal: Blood (2022)
Leonurine Promotes the Maturation of Healthy Donors and Multiple Myeloma Patients Derived-Dendritic Cells
Authors: Cheng Chen, Lin He, Xi Wang, Zichen Ye, Rong Xiao, Hong Zheng, Shu Chen, Hui Li, Xi Yang, Xuemei Wang, Yu Wang, Xuemei Ye, Xiaobing Huang, Jingying Dai
Journal: Blood (2022)
Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation
Authors: Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, M.Lia Palomba, Santosha Vardhana, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood (2022)
<i>ASXL1</i> Is a Risk Factor for Thrombosis in Polycythemia Vera
Authors: Yuhui Zhang, Guangshuai Teng, Chenxiao Du, Yan Wang, Naibo Hu, Yingdi Han, Jinyu Ma, Shan Gao, Guangpeng Xiang, Zonghong Shao, Jie Bai
Journal: Blood (2022)
Phase 1 Safety and Dose Escalation of Purinostat Mesylate, a Uniquely Potent and Selective Inhibitor of HDAC I and IIb in Relapsed or Refractory Lymphoma and Multiple Myeloma
Authors: Jie Wang, He Li, Linyu Yang, Ailin Zhao, Peng Zhao, Jishi Wang, Jin Xiang, Jia Miao, Li Zheng, Yongsheng Wang, Lijuan Chen, Ting Niu
Journal: Blood (2022)
CD19-Targeted CAR-T Cells in Refractory Systemic Lupus Erythematosus: Safety, Efficacy, and Mechanistic Insights from the First Five Patients
Authors: Fabian Mueller, Simon Voelkl, Dimitrios Mougiakakos, Sebastian Boeltz, Michael Aigner, Regina Gary, Sascha Kretschmann, Soraya Kharboutli, Arnd Kleyer, David Simon, Wolf Rösler, Katharina M. Habenicht, Thomas H. Winkler, Gerhard Krönke, Georg Schett, Andreas Mackensen
Journal: Blood (2022)
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed and Refractory Follicular Lymphoma: Analysis of Safety, Efficacy, and Minimal Residual Disease
Authors: Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, James D. Phelan, Jillian Simard, Jagan R. Muppidi, Craig J. Thomas, Michele Ceribelli, Frances Anne Tosto, Rafic J. Farah, Seung Tae Lee, Amynah Pradhan, Anna Marie Juanitez, Seth M. Steinberg, Elaine S. Jaffe, Mark Roschewski, Louis M. Staudt, Wyndham H. Wilson
Journal: Blood (2022)
Interim Results from an Ongoing Phase 1/2 Study of Lentiviral-mediated <i>Ex-vivo</i> Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Authors: Claire Booth, Julián Sevilla, Gayatri R. Rao, Maria Chitty Lopez, Elena Almarza, Dayna Terrazas, Josune Zubicaray, Marta González Vicent, Kritika Chetty, Grainne O'Toole, Jinhua Xu-Bayford, Eileen Nicoletti, Augustine Fernandes, Caroline Kuo, Satiro de Oliveira, Theodore B. Moore, Grace Choi, Miriam Zeini, Cristina Mesa-Núñez, Adrian J. Thrasher, Juan A. Bueren, Jonathan D. Schwartz, Donald B. Kohn
Journal: Blood (2022)
Outcome of ALL in Adult Patient with Down Syndrome, Single Center Experience
Authors: Salman Alharbi, Maria Agustina Perusini, Sita Bhella, Mark D. Minden, Dawn Maze, Vikas Gupta, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Steven M. Chan, Aniket Bankar, Marta B. Davidson, Guillaume Richard-Carpentier, Jad Sibai, Hassan Sibai
Journal: Blood (2022)
Characterizing the Development of Secondary Myelodysplastic Syndrome (MDS) with Antecedent or Concurrent Chronic Lymphocytic Leukemia (CLL) in the Era of Small Molecule Inhibitors for the Treatment of CLL
Authors: Kristin L Koenig, Prachi Jain, Ying Huang, Kerry A. Rogers, Seema A. Bhat, Jennifer A. Woyach, Michael R. Grever, Uma Borate, Alice S. Mims, Daniel Jones, Cecelia Miller, James S. Blachly, Adam S Kittai
Journal: Blood (2022)
Initial Results from a Phase 1/2 Dose Escalation and Expansion Study Evaluating MS-553, a Novel and Selective PKCβ Inhibitor, in Patients with CLL/SLL
Authors: James S. Blachly, Deborah M. Stephens, J Christine Ye, Nicole Lamanna, Nitin Jain, Michael Niesman, Kai Zhang, Jennifer A. Woyach
Journal: Blood (2022)
Biochemical Engraftment and Clinical Outcomes Following Ex-Vivo Autologous Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA
Authors: Robert F Wynn, Jane L Kinsella, Rebecca J Holley, Jane Potter, Adrian J. Thrasher, Claire Booth, Karen Buckland, Natalia Izotova, Stewart Rust, Daniel Weisberg, Heather J Church, Karen L Tylee, Kathryn L Brammeier, Helena Lee, Laura Ford, Atusa Sadegholnejat, Simon A Jones, Stuart Ellison, Brian Bigger
Journal: Blood (2022)
Outcomes in Patients with Chronic Myeloid Leukemia in the Chronic Phase Randomized to Dasatinib or Imatinib after Suboptimal Responses to 3 Months of Imatinib Therapy: Final 5-Year Results from DASCERN
Authors: Jorge E. Cortes, Qian Jiang, Jianxiang Wang, Jianyu Weng, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong-Wook Kim, Jerald Radich, Michael R. Savona, Patricia Martin-Regueira, Oumar Sy, Giuseppe Saglio
Journal: Blood (2022)
Interferon-alpha2 Favorably Impacts Deregulated Atherosclerosis Genes in Polycythemia Vera and Related Neoplasms
Authors: Vibe Skov, Mads Thomassen, Lasse Kjær, Morten Kranker Larsen, Christina Ellervik, Trine Alma Knudsen, Torben A. Kruse, Hans Carl Hasselbalch
Journal: Blood (2022)
Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT
Authors: Thomas Luft, Luuk Gras, Linda Kostner, Nicolaus Kröger, Thomas Schroeder, Uwe Platzbecker, Johannes Schetelig, Régis Peffault de Latour, Matthias Stelljes, Henrik Sengeloev, Arnold Ganser, Igor Wolfgang Blau, Peter Dreger, Ibrahim Yakoub-Agha, Johan Maertens, Urpu Salmenniemi, Wolfgang Bethge, Stephan Mielke, Guido Kobbe, Anastasia Pouli, Liesbeth C. de Wreede, Kavita Raj, Joanna Drozd-Sokolowska, Donal P. McLornan, Marie Robin
Journal: Blood (2022)
Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking
Authors: Yan Yuan, Qian Wang, Dongxiao Zhuang, Tianling Ding, Hong Chen, Fengping Zhu, Kang Zheng, Rui Feng, Jiajun Zheng, Xiaoluo Zhang, Zunguo Du, Ping Zhu, Jinsong Wu, Ying Mao, Tong Chen
Journal: Blood (2022)
Regulation of Oxidative Energy Metabolism By G0S2 in FLT3+ AML
Authors: Mayra A. Gonzalez, Jose L. Lopez, Vanessa V. Velazquez, Mariah Perkins, Idaly M. Olivas, Alfonso E. Bencomo, Andres J. Rubio, Jehu N. Apaflo, Sudip Bajpeyi, Anna M. Eiring
Journal: Blood (2022)
Modifiable Risk Factors Are Associated with Reduced Bone Mineral Density and Fractures in a National Cohort of 2,003 Dutch Childhood Cancer Survivors
Authors: Demi T.C. de Winter, Jenneke E. Van Atteveld, Vincent G. Pluimakers, Marta Fiocco, Rutger A.J. Nievelstein, Monique G.G. Hobbelink, Andrica C.H. de Vries, Jacqueline J. Loonen, Eline Van Dulmen-den Broeder, Helena J. van der Pal, Saskia M.F. Pluijm, Leontien C.M. Kremer, Cécile M. Ronckers, Margriet van der Heiden-van der Loo, Birgitta Versluys, Marloes Louwerens, Dorine Bresters, Hanneke M. van Santen, Daniel S. Olsson, Imo Hoefer, Sjoerd A.A. van den Berg, Jaap den Hartogh, Wim J.E. Tissing, Sebastian J.C.M.M. Neggers, Marry M. van den Heuvel-Eibrink
Journal: Blood (2022)
Bleeding Risk in Atrial Fibrillation and Thrombocytopenia: A Propensity Matched Cohort Study
Authors: Varun Iyengar, Rushad Patell, Siyang Ren, Sirui Ma, Amanda Pinson, Amelia Barnett, Pavania Elavalakanar, Donna S. Neuberg, Jeffrey I. Zwicker
Journal: Blood (2022)
Germline Variants in <i>MDM4</i> Cause a Disorder of p53 Dysregulation and Insufficient Telomere Maintenance
Authors: Robert Meyer, Matthias Begemann, Marcus Jakob, Claudia Khurana, Daniela Dey, Tarek Hanafee Alali, Heinz Gabriel, Kim Kricheldorf, Margherita Vieri, Susanne Isfort, Martin Kirschner, Jens Panse, Udo Kontny, Selim Corbacioglu, Tim H. Brümmendorf, Ingo Kurth, Fabian Beier
Journal: Blood (2022)
Clinical Outcome and Treatment-Related Mortality in Patients with Acute Myeloid Leukemia Treated at the Uganda Cancer Institute
Authors: Clement Dove Okello, Soheil Meshinchi, Katherine Tarlock, Edus H. Warren, Andrea M.H. Towlerton, Henry Ddungu, Yusuf Mulumba, Fadhil Geriga, Jackson Orem, Joyce K. Balagadde
Journal: Blood (2022)
Variability of Definition of High-Risk Multiple Myeloma in Phase III Clinical Trials
Authors: Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi
Journal: Blood (2022)
Monogenic and Polygenic Contributions to Venous Thromboembolism (VTE) and Splanchnic Thrombosis in Patients (pts) with Pancreatic Cancer (PC)
Authors: Amin H Nassar, Stefan Groha, Edward El-am, Antoine Bejjani, Talal El Zarif, Tarek H. Mouhieddine, Sarah Abou Alaiwi, Elio Adib, Kimmie Ng, Jean M. M Connors, Alfred I Lee, Alexander Gusev
Journal: Blood (2022)
Targeting N-Myristoylation for Adult Acute Myeloid Leukemia Therapy
Authors: Jay Gamma, Erwan Beauchamp, Qiang Liu, Aishwarya Iyer, Megan Yap, Zoulika Zak, Cassidy Ekstrom, Krista Vincent, Joseph Brandwein, Jean C.Y. Wang, Naveen Pemmaraju, Gautam Borthakur, John R. Mackey, Luc G. Berthiaume
Journal: Blood (2022)
Phase 1 Study of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates, in Adult Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Authors: Jennifer Kimberly Lue, Don A. Stevens, Michael E. Williams, Jason Westin, Reggie Ewesuedo, Alice McDonald, Sagar Agarwal, Patrick Henrick, Rachelle Perea, Jared Gollob
Journal: Blood (2022)
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
Authors: Filip Ionescu, Eloho Ajayi, Aamia Leach, Melissa Alsina, Nelli Bejanyan, Omar Castaneda-Puglianini, Hany Elmariah, Ciara L. Freeman, Doris K. Hansen, Michael D. Jain, Farhad Khimani, Aleksandr Lazaryan, Hien D. Liu, Frederick L. Locke, Bryan McIver, Asmita Mishra, Michael Nieder, Jose Ochoa, Lia Perez, Joseph Pidala, Aliyah Baluch, Olga Klinkova, Rod Quilitz, Taiga Nishihori, Rawan Faramand
Journal: Blood (2022)
Microenvironment Immune Cells in Bone Marrow and Lymph Node Measured By Flow Cytometry Have Prognostic Impact on Survival in Nodal Non-Hodgkin T-Cell Lymphoma
Authors: Laura Korin, Maria Lucia Fuente, Santiago Cranco, Paola Ochoa, Adriana Vitriu, Evelina Babuin, Olivia Gelo, Luis Ayala, Paula Tempra, Andrea Novoa, Maria Belen Venegas, Anahí Vijnovich Baron, Maria Del Rosario Custidiano, Norma Elisabeth Tartas, Maria Cecilia Foncuberta, Julio Cesar Sanchez Avalos
Journal: Blood (2022)
Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib in IDH Mutated Acute Myeloid Leukemia
Authors: Himachandana Atluri, Abhishek Maiti, Koji Sasaki, Naval Daver, Yesid Alvarado, Md Feroz Hossain, Xuemei Wang, Naveen Pemmaraju, Koichi Takahashi, Gautam Borthakur, Alessandra Ferrajoli, Nicholas Short, Hussein A Abbas, Farhad Ravandi, Elias Jabbour, Michael Andreeff, Guillermo Garcia-Manero, Hagop Kantarjian, Marina Konopleva, Courtney D. DiNardo
Journal: Blood (2022)
Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
Authors: Michael L. Wang, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian W. Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, Ewa Lech-Marańda, Joanna M. Rhodes, Krish Patel, Jennifer A. Woyach, Nicole Lamanna, Yucai Wang, Constantine S. Tam, John F. Seymour, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Andrew D. Zelenetz, Preetesh Jain, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo B. Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato
Journal: Blood (2022)
PIM Inhibition By SEL24/MEN1703 Combines Synergistically with Gilteritinib in FLT3-ITD Preclinical Models of Acute Myeloid Leukemia
Authors: Daniela Bellarosa, Sonia Zicari, Giuseppe Merlino, Alessio Fiascarelli, Diego Bisignano, Francesco Belli, Clelia Irrissuto, Simone Talucci, Maria Luisa Iannitto, Mario Bigioni, Alessandro Bressan, Krzysztof Brzózka, Gabriel Ghiaur, Monica Binaschi
Journal: Blood (2022)
Anti CD19 CAR-T Cell Therapy Can Clear Minimal Residual Disease in Bone Marrow of Patients with Relapsed or Refractory B Cell Non-Hodgkin's Lymphomas
Authors: Armaan Dhaliwal, Mahima Zandu, Sharad Khurana, Abhijeet Kumar, Jeffrey J. Pu, Emmanuel Katsanis, Muhammad Husnain
Journal: Blood (2022)
Antileukemic Activity of Ypn-005, a CDK7 Inhibitor, Inducing Apoptosis through c-MYC and FLT3 Suppression in Acute Myeloid Leukemia
Authors: Bon-Kwan Koo, Je-Hwan Lee, Eun-Ji Choi, Eun-Hye Hur, Ju Hyun Moon, Ji Yun Kim, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo Hyung Lee, Jinhwan Kim
Journal: Blood (2022)
The Added Value of Multi-State Modelling in Acute Myeloid Leukemia: The Gimema AML1310 Study Post-Hoc Analysis
Authors: Alfonso Piciocchi, Valentina Arena, Monica Messina, Sonia Maria Orlando, Raffaele Palmieri, Luca Maurillo, Maria Ilaria Del Principe, Paola Fazi, Marco Vignetti, Francesco Buccisano, Adriano Venditti
Journal: Blood (2022)
Clinical and Epidemiological Features and Therapeutic Options of Avascular Necrosis in Sickle Cell Patients: A Cross-Sectional Study
Authors: Awni Alshurafa, Mohammad Abu-Tineh, Hana Qasim, Abdulqadir Jeprel Nashwan, Khadra Yassin, Farah Rahat Rashid, Mohammad Khair Eddin Hemadneh, Mohamed A. Yassin
Journal: Blood (2022)
Diffuse myocardial fibrosis occurs in young patients with sickle cell anemia despite early disease-modifying therapy
Authors: Cara E. Morin, Akshay Sharma, Subodh Selukar, Gary Beasley, Anthony Merlocco, Chris Goode, Parul Rai, Jeffrey A. Towbin, Jane S. Hankins, Jason N. Johnson
Journal: Blood (2022)
Pediatric Preclinical Testing Consortium Evaluation of the MCL1 Inhibitor, AMG 176, Against Xenograft Models of Acute Lymphoblastic Leukemia
Authors: Richard B Lock, Kathryn Evans, Ben Watts, Joanna Randall, Cara E Toscan, Eric J Earley, Stephen W Erickson, Brian Belmontes, Philip Wong, Beverly A Teicher, Paul E Hughes, Malcolm A Smith
Journal: Blood (2022)
Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
Authors: Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder
Journal: Blood (2022)
Phase Ib/II Study of Rituximab, Lenalidomide and Methotrexate Followed By Lenalidomide Maintenance in Patients with Newly Diagnosed Primary CNS Lymphoma: The Remla Trial
Authors: Yan Zhang, Wei Wang, Jian Li, Daobin Zhou, Wei Zhang, Danqing Zhao, Chong Wei, Lu Zhang, Xinxin Cao
Journal: Blood (2022)